Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q3 2015 · 10-Q
Revenue$52.87K$52.87K−80.8% vs Q3 2014 Net Income-$3.94M-$3.94MN/M vs Q3 2014 EPS Diluted$0.06$0.06N/M vs Q3 2014 Gross Profit$40,345−82.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Operating Cash Flowderived-$208,437N/M Free Cash Flowderived-$208,437— Margins · derivedGross margin76.3%−5.4 pt vs Q3 2014
Operating margin-7408.3%−7218.2 pt vs Q3 2014
Net margin-7449.4%−7374.8 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 23, 2015 · 54 d after period end